Heart failure & cardiomyopathies
Paediatric Heart Transplantation During the COVID-19 Pandemic in Iran: Single-Centre Experience
Authors' conclusion
Throughout the pandemic, although we experienced a reduction in the transplant rate in the first year, with the increasing vaccination rate in health care and later in the general population, we continued to maintain our transplant rate by incorporating safety protocols and more resources.
Study context
- Population
- Paediatric heart transplant recipients, single centre in Iran
- Participants
- 59 vs 62
- Exposure
- Paediatric heart transplantation during the COVID-19 pandemic vs before the pandemic
- February 2020 to February 2022n = 59
- February 2018 to 2020n = 62reference
- Outcome
- Transplant rate and early outcomes during the pandemic
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
- Heart transplant rate in first pandemic year vs year before the pandemic: reduced
- 34%
- Heart transplant rate in second pandemic year: increase
- 19%
- In-hospital mortality rate during the 2-year pandemic
- 11.8%
- In-hospital COVID-19 infection rate
- 11 patients (18%)
- Overall 30-day survival rate
- 88%
- 30-day rejection rate
- 10%
Observational data: associations, not effects.
Further findings
Echocardiographic function during first month of follow-up
- Mean LVEF
- 53.6 ± 4.9
- Mean LV global longitudinal strain
- −16.9 ± 3.3
- Mean RV global longitudinal strain
- −17.0 ± 3.8
- No significant difference between patients with in-hospital COVID and other recipients
- P = 0.1, P = 0.2 and P = 0.2
Death related to COVID-19 acute respiratory distress syndrome
- Deaths related to COVID-19 ARDS
- 1
Original publication
Paediatric Heart Transplantation During the COVID-19 Pandemic in Iran: Single-Centre Experience. ESC Heart Fail. Published 21 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →